We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR ...

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

ZUG, Switzerland and BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Charles Schwab Investment Management Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 0.2% during the 4th quarter, HoldingsChannel.com reports.The fund owned ...

US Bancorp DE lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 53.3% during the 4th quarter, Holdings Channel reports.The firm owned 1,209 shares of the ...

A month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 0.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...

Equities researchers at Zacks Research upped their Q2 2025 earnings estimates for CRISPR Therapeutics in a report issued on ...

In other significant trading activity, ARK continued to bolster its position in CRISPR Therapeutics AG (NASDAQ: CRSP ), purchasing 24,324 shares across its ARKK and ARKG ETFs, totaling nearly $1 ...